• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

How Low Might Medicare's Drug Payout Go?

Article

By upholding the health-care overhaul, the Supreme Court keeps on track plans to eliminate a gap in Medicare’s Part D prescription-drug benefit, a popular provision among patients. Does the decision also set a course toward cutting what Medicare itself pays for drugs?

The so-called doughnut hole — designed to reduce the government’s spending on the benefit — has been tough on many seniors. This year, it requires them to pay the costs of their prescriptions when the tab comes in between $2,930 and $6,658. Above that, catastrophic insurance coverage kicks in, and patients typically pay just 5% of their drug costs.

Read the full story: http://tinyurl.com/cfem9rr

Source: The Wall Street Journal

Related Videos
Margaret Krackeler, MD
Philip Mease, MD
A new study finds law enforcement presence in emergency departments may disrupt care. Lead author Prashasti Bhatnagar discusses policy and training solutions.
Jennifer Snow, MPA, NAMI
Jennifer Snow, MPA, NAMI
Most employees are unprepared to shop for coverage on their own, underscoring the need for stronger decision tools and consumer protections.
Experts warn that ICHRAs could either stabilize or destabilize the individual market, depending on which workers employers shift into these plans.
Aleata Postell, SVP of pharmacy business development, CenterWell Pharmacy
Where patients live may shape outcomes in hypertrophic cardiomyopathy, with SDOH linked to higher risks of heart failure and arrhythmias.
Adam Brufsky, MD, PhD, University of Pittsburgh
Related Content
© 2026 MJH Life Sciences
AJMC®
All rights reserved.